Glycemicon. Market Entry Into The Indian Pharmaceutical Market

Research Paper (undergraduate) , 2016 , 18 Pages , Grade: 5,5/6

Business economics - Trade and Distribution

The following paper analyzes the Indian pharmaceutical market in terms of drugs against diabetes in India and the market entry of the Swiss Start-up Glycemicon. In order to fulfill the given tasks, the target market will be analyzed and a brief recommendation for a possible market entry of Glycemicon will be given. The results of the paper are that the combination of the innovative product of the Swiss Start-up and the opportunities the Indian market offers, make a market entry through the form of an Alliance or a Joint Venture very promising.

Table of contents

ABSTRACT

1. INTRODUCTION

2. GLYCEMICON

3. MARKET ANALYSIS
3.1 BACKGROUND
3.2 DIABETES PHARMACEUTICALS IN THE INDIAN MARKET

4. COMPETITION ANALYSIS
4.1 POWER OF SUPPLIERS
4.2 ENTRY BARRIERS
4.3 THREAT OF SUBSTITUTES
4.4 POWER OF BUYERS
4.5 INDUSTRY COMPETITION

5. RECOMMENDATIONS FOR THE MARKET ENTRY PLANNING

6. CONCLUSION

BIBLIOGRAPHY

LIST OF TABLES

LIST OF FIGURES

• College: University of St. Gallen
• Grade: 5,5/6
• Author: Lukas Dietrich (Author)
• Publication Year: 2016
• Pages: 18
• Catalog Number: V420554
• ISBN (eBook): 9783668685611
• ISBN (Book): 9783668685628
• Language: English
• Tags: Market Entry Strategy